These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25320620)

  • 1. Validation of risk assessment models for predicting the incidence of breast cancer in korean women.
    Min JW; Chang MC; Lee HK; Hur MH; Noh DY; Yoon JH; Jung Y; Yang JH;
    J Breast Cancer; 2014 Sep; 17(3):226-35. PubMed ID: 25320620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
    Wang X; Huang Y; Li L; Dai H; Song F; Chen K
    Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Korean risk assessment model for breast cancer risk prediction.
    Park B; Ma SH; Shin A; Chang MC; Choi JY; Kim S; Han W; Noh DY; Ahn SH; Kang D; Yoo KY; Park SK
    PLoS One; 2013; 8(10):e76736. PubMed ID: 24204664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
    Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
    BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.
    Pastor-Barriuso R; Ascunce N; Ederra M; Erdozáin N; Murillo A; Alés-Martínez JE; Pollán M
    Breast Cancer Res Treat; 2013 Feb; 138(1):249-59. PubMed ID: 23378108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
    Rockhill B; Spiegelman D; Byrne C; Hunter DJ; Colditz GA
    J Natl Cancer Inst; 2001 Mar; 93(5):358-66. PubMed ID: 11238697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory Accuracy of the Gail Model for Breast Cancer Risk Assessment among Iranian Women.
    Rostami S; Rafei A; Damghanian M; Khakbazan Z; Maleki F; Zendehdel K
    Iran J Public Health; 2020 Nov; 49(11):2205-2213. PubMed ID: 33708742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
    Chay WY; Ong WS; Tan PH; Jie Leo NQ; Ho GH; Wong CS; Chia KS; Chow KY; Tan M; Ang P
    Breast Cancer Res; 2012 Jan; 14(1):R19. PubMed ID: 22289271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
    Chen J; Pee D; Ayyagari R; Graubard B; Schairer C; Byrne C; Benichou J; Gail MH
    J Natl Cancer Inst; 2006 Sep; 98(17):1215-26. PubMed ID: 16954474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study.
    Stojadinovic A; Eberhardt C; Henry L; Eberhardt J; Elster EA; Peoples GE; Nissan A; Shriver CD
    Eplasty; 2010 Mar; 10():e25. PubMed ID: 20418939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Tyrer-Cuzick Versus Gail Risk Modeling in Predicting Benefit from Screening MRI in Breast Cancer.
    Sevdalis A; Deng X; Bandyopadhyay D; McGuire KP
    Eur J Breast Health; 2022 Jan; 18(1):79-84. PubMed ID: 35059595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk assessments comparing Gail and CARE models in African-American women.
    Adams-Campbell LL; Makambi KH; Frederick WA; Gaskins M; Dewitty RL; McCaskill-Stevens W
    Breast J; 2009; 15 Suppl 1(0 1):S72-5. PubMed ID: 19775333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
    Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
    Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort.
    Decarli A; Calza S; Masala G; Specchia C; Palli D; Gail MH
    J Natl Cancer Inst; 2006 Dec; 98(23):1686-93. PubMed ID: 17148770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.